loadpatents
name:-0.030663013458252
name:-0.017253160476685
name:-0.0069620609283447
Yan; Hongxing Patent Filings

Yan; Hongxing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yan; Hongxing.The latest application filed is for "ether linked triazoles as nrf2 activators".

Company Profile
6.14.28
  • Yan; Hongxing - King of Prussia PA
  • Yan; Hongxing - Collegeville PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ether Linked Triazoles As Nrf2 Activators
App 20220089590 - Cooper; Anthony William James ;   et al.
2022-03-24
Bisaryl Lactams As Nrf2 Activators
App 20220002272 - BOEHM; Jeffrey Charles ;   et al.
2022-01-06
Ether linked triazoles as NRF2 activators
Grant 11,059,816 - Cooper , et al. July 13, 2
2021-07-13
Nrf2 REGULATORS
App 20200079759 - KERNS; Jeffrey K. ;   et al.
2020-03-12
Ether Linked Triazoles As Nrf2 Activators
App 20200071317 - COOPER; Anthony William James ;   et al.
2020-03-05
Nrf2 regulators
Grant 10,485,806 - Kerns , et al. Nov
2019-11-26
Nrf2 REGULATORS
App 20190224212 - Kerns; Jeffrey K. ;   et al.
2019-07-25
NRF2 regulators
Grant 10,272,095 - Kerns , et al.
2019-04-30
NRF2 Regulators
App 20190002454 - BOEHM; Jeffrey Charles ;   et al.
2019-01-03
Nrf2 REGULATORS
App 20180179167 - KERNS; Jeffrey K. ;   et al.
2018-06-28
Nrf2 REGULATORS
App 20180179187 - KERNS; Jeffrey K. ;   et al.
2018-06-28
Nrf2 REGULATORS
App 20180169110 - KERNS; Jeffrey K. ;   et al.
2018-06-21
Nrf2 Regulators
App 20160318917 - Boehm; Jeffrey Charles ;   et al.
2016-11-03
Dual pharmacophores--PDE4-muscarinic antagonistics
Grant 8,084,449 - Callahan , et al. December 27, 2
2011-12-27
Dual pharmacophores--PDE4-muscarinic antagonistics
Grant 8,071,588 - Callahan , et al. December 6, 2
2011-12-06
Dual pharmacophores--PDE4-muscarinic antagonistics
Grant 8,067,408 - Callahan , et al. November 29, 2
2011-11-29
M3 muscarinic acetylcholine receptor antagonists
Grant 7,906,531 - Wan , et al. March 15, 2
2011-03-15
Novel Compounds
App 20100093766 - CALLAHAN; James F. ;   et al.
2010-04-15
Novel Compounds
App 20100093765 - CALLAHAN; James F. ;   et al.
2010-04-15
Compounds
Grant 7,674,789 - Callahan , et al. March 9, 2
2010-03-09
M3 Muscarinic Acetylcholine Receptor Antagonists
App 20090275604 - WAN; ZEHONG ;   et al.
2009-11-05
Novel Compounds
App 20090239846 - Callahan; James F. ;   et al.
2009-09-24
Muscarinic acetylcholine receptor antagonists
Grant 7,579,361 - Busch-Petersen , et al. August 25, 2
2009-08-25
Muscarinic acetylcholine receptor antagonists
Grant 7,576,096 - Busch-Petersen , et al. August 18, 2
2009-08-18
Dual Pharmacophores - PDE4-Muscarinic Antagonistics
App 20090203677 - Callahan; James Francis ;   et al.
2009-08-13
Dual Pharmacophores - PDE4-Muscarinic Antagonistics
App 20090203657 - Callahan; James Francis ;   et al.
2009-08-13
Dual Pharmacophores - PDE4-Muscarinic Antagonistics
App 20090197871 - Callahan; James Francis ;   et al.
2009-08-06
M.sub.3 muscarinic acetylcholine receptor antagonists
Grant 7,563,803 - Wan , et al. July 21, 2
2009-07-21
Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives
App 20090048444 - Callahan; James F. ;   et al.
2009-02-19
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
Grant 7,479,558 - Callahan , et al. January 20, 2
2009-01-20
Muscarinic acetylcholine receptor antagonists
Grant 7,439,255 - Wan , et al. October 21, 2
2008-10-21
Novel Compounds
App 20080051416 - Boehm; Jeffrey Charles ;   et al.
2008-02-28
M3 Muscarinic Acetylcholine Receptor Antagonists
App 20070270456 - Wan; Zehong ;   et al.
2007-11-22
Muscarinic Acetylcholine Receptor Antagonists
App 20070244150 - Busch-Petersen; Jakob ;   et al.
2007-10-18
Muscarinic Acetylcholine Receptor Antagonists
App 20070238752 - Busch-Petersen; Jakob ;   et al.
2007-10-11
Muscarinic acetylcholine receptor antagonists
Grant 7,276,521 - Busch-Petersen , et al. October 2, 2
2007-10-02
M3 muscarinic acetylchoine receptor antagonists
App 20070185148 - Busch-Petersen; Jakob ;   et al.
2007-08-09
Muscarinic acetylcholine receptor antagonists
App 20070129396 - Wan; Zehong ;   et al.
2007-06-07
Muscarinic acetycholine receptor antagonists
App 20070105895 - Busch-Petersen; Jakob ;   et al.
2007-05-10
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
App 20060258687 - Boehm; Jeffrey C. ;   et al.
2006-11-16
Novel compounds
App 20060235030 - Callahan; James F. ;   et al.
2006-10-19
Quinoline derivatives as nk-2 and nk-3 receptor antagonists
App 20060094726 - Kerns; Jeffrey ;   et al.
2006-05-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed